DeepMed Research

University Of Louisville

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1798-01-01

Employees: 5K

Market Cap: -

Website: http://www.louisville.edu

Clinical Trials

Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer

Phase 2

Terminated

Conditions: Non-small Cell Lung Cancer

Interventions: Dietary Supplement: Blueberry powder

First Posted Date: 2011-08-31

Last Posted Date: 2018-03-05

Lead Sponsor: University of Louisville

Target Recruit Count: 4

Registration Number: NCT01426620

Locations: 🇺🇸
James Graham Brown Cancer Center, Louisville, Kentucky, United States

Louisville Teen Pregnancy Prevention Project

Not Applicable

Completed

Conditions: Pregnancy
Sexually Transmitted Diseases

Interventions: Behavioral: Reducing the Risk
Behavioral: Love Notes

First Posted Date: 2011-08-08

Last Posted Date: 2017-04-24

Lead Sponsor: University of Louisville

Target Recruit Count: 1450

Registration Number: NCT01411878

Locations: 🇺🇸
Department for Community Based Services: Jefferson County Region, Louisville, Kentucky, United States
🇺🇸
House of Ruth, Louisville, Kentucky, United States
🇺🇸
Presbyterian Community Center, Louisville, Kentucky, United States

and more 9 locations

Phase II Study of Simvastatin for Relapsed/Refractory Myeloma

Phase 2

Withdrawn

Conditions: Myeloma

Interventions: Drug: Simvastatin,Zoledronic Acid,Bortezomib,Bendamustine,Methylprednisolone.

First Posted Date: 2011-04-11

Last Posted Date: 2017-12-29

Lead Sponsor: University of Louisville

Registration Number: NCT01332617

STEREOtactic Radiation and Chemotherapy in Lung Cancer (STEREO)

Not Applicable

Withdrawn

Conditions: Non-small Cell Lung Cancer (NSCLC)

Interventions: Radiation: Stereotactic Body Radiation Therapy

First Posted Date: 2011-02-21

Last Posted Date: 2018-03-05

Lead Sponsor: University of Louisville

Registration Number: NCT01300299

Locations: 🇺🇸
James Graham Brown Cancer Center, Louisville, Kentucky, United States

Study Investigating the Ability of Plant Exosomes to Deliver Curcumin to Normal and Colon Cancer Tissue

Not Applicable

Recruiting

Conditions: Colon Cancer

Interventions: Dietary Supplement: Curcumin conjugated with plant exosomes
Dietary Supplement: curcumin
Other: No intervention

First Posted Date: 2011-02-11

Last Posted Date: 2023-12-20

Lead Sponsor: University of Louisville

Target Recruit Count: 35

Registration Number: NCT01294072

Locations: 🇺🇸
University of Louisville Hospital, Louisville, Kentucky, United States

Plethysmography Variability Index as an Indicator of Adequacy of Preload

Completed

Conditions: Gynecological Surgery

First Posted Date: 2011-01-28

Last Posted Date: 2021-04-05

Lead Sponsor: University of Louisville

Target Recruit Count: 77

Registration Number: NCT01285622

Locations: 🇺🇸
University of Louisville Hospital, Louisville, Kentucky, United States

Accelerated Hypofractionated Radiotherapy (AHF-RT) for the Treatment of Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Radiation: accelerated hypofractionated radiotherapy (AHF-RT)

First Posted Date: 2011-01-17

Last Posted Date: 2024-02-22

Lead Sponsor: University of Louisville

Target Recruit Count: 158

Registration Number: NCT01278212

Locations: 🇺🇸
James Graham Brown Cancer Center, Louisville, Kentucky, United States

Advanced Cervical Cancer Trial in India

Phase 2

Completed

Conditions: Cervical Cancer

Interventions: Drug: Cisplatin and radiation
Drug: Interferon, Retinoic Acid and radiation

First Posted Date: 2011-01-13

Last Posted Date: 2017-12-29

Lead Sponsor: University of Louisville

Target Recruit Count: 209

Registration Number: NCT01276730

Locations: 🇮🇳
Chittaranjan National Cancer Institute, Kolkata, India

Rapid Empiric Treatment With Oseltamivir Study (RETOS)

Phase 4

Completed

Conditions: Pneumonia
Influenza

Interventions: Drug: oseltamivir

First Posted Date: 2010-11-25

Last Posted Date: 2023-06-15

Lead Sponsor: University of Louisville

Target Recruit Count: 1107

Registration Number: NCT01248715

Locations: 🇺🇸
Norton Hospital, Louisville, Kentucky, United States
🇺🇸
Rex Robley VA Medical Center, Louisville, Kentucky, United States
🇺🇸
Baptist Hospital East, Louisville, Kentucky, United States

and more 2 locations

Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma

Phase 1

Completed

Conditions: Osteogenic Sarcoma
Neuroblastoma
Ewings Sarcoma
Rhabdomyosarcoma
Synovial Sarcoma

Interventions: Biological: Autologous dendritic cell vaccine with adjuvant

First Posted Date: 2010-11-16

Last Posted Date: 2017-05-09

Lead Sponsor: University of Louisville

Target Recruit Count: 19

Registration Number: NCT01241162

Locations: 🇺🇸
University of Louisville, Kosair Charities Pediatric Clinical Research Unit, Louisville, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy